Biological and psychosocial pathophysiology of female sexual dysfunction during the menopausal transition

被引:114
作者
Graziottin, A [1 ]
Leiblum, SR
机构
[1] H San Raffaele Resnati, Ctr Gynecol & Med Sexol, Milan, Italy
[2] Univ Florence, Postgrad Course Sexual Med, I-50121 Florence, Italy
[3] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Ctr Sexual & Relationship Hlth, Piscataway, NJ 08854 USA
关键词
menopause; sexuality; sexual hormones; estrogens; progestogens; testosterone; hormone therapy; female sexual disorders;
D O I
10.1111/j.1743-6109.2005.00129.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction. Although increasing age is a primary determinant of reduced sexual function in older women, hormonal changes may be significant contributors to female (and couples') sexual dysfunction. Aim. To analyze the most relevant biological, psychosexual, and/or contextual factors that influence changes in women's sexuality during and after menopause. Methods. A Postmenopausal FSD Roundtable consisting of multidicsiplinary international experts was convened to review specific issues related to postmenopausal women and sexual dysfunction. Main Outcome Measure. Expert opinion was based on a review of evidence-based medical literature, presentation, and internal discussion. Results. Menopause is associated with physiological and psychological changes that influence sexuality: the primary biological change is a decrease in circulating estrogen levels. Estrogen deficiency initially accounts for irregular menstruation and diminished vaginal lubrication. Continual estrogen loss is associated with changes in the vascular, muscular, and urogenital systems, and also alterations in mood, sleep, and cognitive functioning, influencing sexual function both directly and indirectly. The age-dependent decline in testosterone and androgen function, starting in the early 20s, may precipitate or exacerbate aspects of female sexual dysfunction; these effects are most pronounced following bilateral ovariectomy and consequent loss of 50% or more total testosterone. The contribution of progestogens to sexual health and variability in the effects of specific progestogens are being increasingly appreciated. Comorbidities, influenced by loss of sexual hormones, between mood and desire disorders and urogenital and sexual pain disorders are common and remain frequently overlooked in clinical practice. Physical and psychosexual changes may contribute to lower self-esteem, and diminished sexual, responsiveness and sexual desire. Nonhormonal factors that affect sexuality are health status and current medication use, changes in or dissatisfaction with partner, partners health and/or sexual problems, and socioeconomic status. Conclusion. Determination of the best way to provide optimal management of sexual dysfunction associated with menopause requires additional controlled studies.
引用
收藏
页码:133 / 145
页数:13
相关论文
共 71 条
[1]  
Alexander JLKK, 2003, PRIM PSYCHIAT, V10, P53
[2]  
ALTHOF S, 2004, SEXUAL MED SEXUAL DY
[3]  
Avis N E, 2001, Climacteric, V4, P243, DOI 10.1080/713605090
[4]   Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups [J].
Avis, NE ;
Stellato, R ;
Crawford, S ;
Bromberger, J ;
Ganz, P ;
Cain, V ;
Kagawa-Singer, M .
SOCIAL SCIENCE & MEDICINE, 2001, 52 (03) :345-356
[5]   Perimenopausal androgen decline after oophorectomy does not influence sexuality or psychological well-being [J].
Aziz, A ;
Brännström, M ;
Bergquist, C ;
Silfverstolpe, G .
FERTILITY AND STERILITY, 2005, 83 (04) :1021-1028
[6]  
Bachmann GA, 2002, FERTIL STERIL, V77, pS72
[7]  
Bancroft J, 2002, FERTIL STERIL, V77, pS55
[8]   Definitions of women's sexual dysfunction reconsidered: advocating expansion and revision [J].
Basson, R ;
Leiblum, S ;
Brotto, L ;
Derogatis, L ;
Fourcroy, J ;
Fugl-Meyer, K ;
Graziottin, A ;
Heiman, JR ;
Laan, E ;
Meston, C ;
Schover, L ;
van Lankveld, J ;
Schultz, WW .
JOURNAL OF PSYCHOSOMATIC OBSTETRICS AND GYNECOLOGY, 2003, 24 (04) :221-229
[9]   Persistent mood symptoms in a multiethnic community cohort of pre- and perimenopausal women [J].
Bromberger, JT ;
Assmann, SF ;
Avis, NE ;
Schocken, M ;
Kravitz, HM ;
Cordal, A .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 158 (04) :347-356
[10]   A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition [J].
Burger, HG ;
Dudley, EC ;
Cui, JS ;
Dennerstein, L ;
Hopper, JL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (08) :2832-2838